B. Fournier

发表

Effects of Mutations in GrlA of Topoisomerase IV from Staphylococcus aureus on Quinolone and Coumarin Activity

D. Hooper, B. Fournier, 1998, Antimicrobial Agents and Chemotherapy.

Recognition of Staphylococcus aureus by the Innate Immune System

D. Philpott, B. Fournier, 2005, Clinical Microbiology Reviews.

The function of TLR2 during staphylococcal diseases

B. Fournier, 2012, Front. Cell. Inf. Microbio..

CD47 and TLR-2 Cross-Talk Regulates Neutrophil Transmigration

E. Peatman, C. Parkos, A. Chin, 2009, The Journal of Immunology.

Neutrophil Transmigration CD 47 and TLR-2 Cross-Talk Regulates

E. Peatman, A. Chin, Winston Y. Lee, 2009 .

Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca

P. H. Roy, B. Fournier, 1997, Antimicrobial agents and chemotherapy.

Cation-Induced Transcriptional Regulation of the dlt Operon of Staphylococcus aureus

A. Peschel, J. Weiss, T. Koprivnjak, 2006, Journal of bacteriology.

Toll-Like Receptor 5-Dependent Regulation of Inflammation in Systemic Salmonella enterica Serovar Typhimurium Infection

I. Williams, A. Gewirtz, A. Neish, 2009, Infection and Immunity.

The role of neutrophils during intestinal inflammation

C. Parkos, B. Fournier, 2012, Mucosal Immunology.

A Mutation in the 5′ Untranslated Region Increases Stability of norA mRNA, Encoding a Multidrug Resistance Transporter of Staphylococcus aureus

Q. C. Truong-Bolduc, D. Hooper, Xiamei Zhang, 2001, Journal of bacteriology.

CD47 and Toll-Like Receptor-2 Cross-Talk Regulates Neutrophil Transmigration

A. Chin, Winston Y. Lee, B. Fournier, 2009 .

The two‐component system ArlS–ArlR is a regulator of virulence gene expression in Staphylococcus aureus

G. Rapoport, A. Klier, B. Fournier, 2001, Molecular microbiology.

Mutations in Topoisomerase IV and DNA Gyrase of Staphylococcus aureus: Novel Pleiotropic Effects on Quinolone and Coumarin Activity

D. Hooper, B. Fournier, 1998, Antimicrobial Agents and Chemotherapy.

Protein A gene expression is regulated by DNA supercoiling which is modified by the ArlS-ArlR two-component system of Staphylococcus aureus.

A. Klier, B. Fournier, 2004, Microbiology.

Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation

S. Koch, R. Hilgarth, A. Nusrat, 2012, Mucosal Immunology.

Selective Targeting of Topoisomerase IV and DNA Gyrase in Staphylococcus aureus: Different Patterns of Quinolone- Induced Inhibition of DNA Synthesis

D. Hooper, Xilin Zhao, K. Drlica, 2000, Antimicrobial Agents and Chemotherapy.

Response to the criticisms of Richard P. Novick in his review ‘Autoinduction and signal transduction in the regulation of staphylococcal virulence’ (Novick, 2003, Mol Microbiol 48: 1429–1449)

A. Klier, B. Fournier, 2003, Molecular microbiology.

Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis.

T. Denning, E. Peatman, S. Koch, 2012, Immunity.

Combined Plasma Elevation of CRP, Intestinal-Type Fatty Acid-Binding Protein (I-FABP), and sCD14 Identify Older Patients at High Risk for Health Care-Associated Infections

Y. Lévy, S. Bastuji‐Garin, E. Paillaud, 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

A New Two-Component Regulatory System Involved in Adhesion, Autolysis, and Extracellular Proteolytic Activity ofStaphylococcus aureus

D. Hooper, B. Fournier, 2000, Journal of bacteriology.

Strength and Regulation of the Different Promoters for Chromosomal β-Lactamases of Klebsiella oxytoca

P. H. Roy, D. Hooper, A. Gravel, 1999, Antimicrobial Agents and Chemotherapy.

Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2

P. H. Roy, P. Lagrange, A. Philippon, 1996, Antimicrobial agents and chemotherapy.

beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca

P. Lagrange, A. Philippon, B. Fournier, 1996, Antimicrobial agents and chemotherapy.

Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca

P. Lagrange, A. Philippon, R. Krishnamoorthy, 1995, Antimicrobial agents and chemotherapy.

Klebsiella oxytoca: Resistance to aztreonam by overproduction of the chromosomally encoded β‐lactamase

P. Lagrange, A. Philippon, G. Arlet, 1994 .

Expression of the Multidrug Resistance Transporter NorA from Staphylococcus aureus Is Modified by a Two-Component Regulatory System

D. Hooper, R. Aras, B. Fournier, 2000, Journal of bacteriology.

In-vitro susceptibility of Klebsiella oxytoca strains to 13 β-lactams in the presence and absence of β-lactamase inhibitors

P. Lagrange, A. Philippon, B. Fournier, 1996 .

CHAPTER 4 – Regulation systems of toxin expression

C. Locht, J. Rood, D. Lereclus, 2006 .

groups, blaOXY-1 and blaOXY-2. Klebsiella oxytoca are divided into two main Chromosomal beta-lactamase genes of

P. H. Roy, P. Lagrange, A. Philippon, 2013 .

Toll-Like Receptor 5-Dependent Regulation of Inﬂammation in Systemic Salmonella enterica Serovar Typhimurium Infection (cid:1)

I. Williams, A. Gewirtz, A. Neish, 2009 .

Surfactant Protein D (Sp-D) Binds to Membrane-proximal Domain (D3) of Signal Regulatory Protein α (SIRPα), a Site Distant from Binding Domain of CD47, while Also Binding to Analogous Region on Signal Regulatory Protein β (SIRPβ)*

D. Voelker, D. Weber, C. Parkos, 2012, The Journal of Biological Chemistry.

DNA complexes obtained with the integron integrase IntI1 at the attI1 site.

P. H. Roy, A. Gravel, A Gravel, 1998, Nucleic acids research.

In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors.

P. Lagrange, A. Philippon, B. Fournier, 1996, The Journal of antimicrobial chemotherapy.

Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis.

T. Denning, E. Peatman, S. Koch, 2012, Immunity.

overproduction in Klebsiella oxytoca. molecular basis of beta-lactamase Point mutation in the pribnow box, the

R. Krishnamoorthy, B. Fournier, C. Y. Lu, 2013 .